OncoNews

Therapy Areas

OncoNews

OncoNews

Lung Icon

Lung Cancer

Uterus Icon

Women's Cancers

Bladder Icon

Urogenital

GI Icon

Gastro-intestinal

Hematology Icon

Hematology

Other Solid Tumor Icon

Other Tumors

Highlighted OncoNews

Viktor Grünwald
Oct 24 2024
Urogenital

Treatment landscape of non-clear cell RCC entities

} 12 min

watch now
Nicolas Girard
Oct 04 2024
Lung Cancer

Best Practices in Managing Adverse Events with ADCs in NSCLC

} 17m 30

watch now

Roundtable Sessions

Breast Cancer by Peter Dubsky
Dec 18 2024
Women's Cancers

Breast Cancer 2024 Review

} 1 h 32 min

watch now
Lung Cancer by Solange Peters
Dec 17 2024
Lung Cancer

Lung Cancer 2024 REVIEW

} 1 h 43 min

watch now
Early NSCLC by Jean Yannis Perentes
Nov 26 2024
Lung Cancer

EARLY NSCLC

} 1 h 37 min

watch now
Uro-Onkologie von Aurelius Omlin
Nov 15 2024
Urogenital

Urogenitale Tumore

} 2 h 19 min

watch now
ADCs by Alessandra Curioni
Nov 06 2024
Antibody Drug Conjugates

Antibody Drug Conjugates

} 1 h 39 min

watch now
GYNE Session by Apostolos Sarivalasis
Sep 26 2024
Women's Cancers

Gynecological Cancers

} 1 h 32 min

watch now
CLL Session by Noémie Lang
Jul 17 2024
Hematology

Chronic lymphocytic leukemia

} 1 h 30 min

watch now
Breast Session by Jens Huober
Jul 02 2024
Women's Cancers

Breast Cancer (ASCO 2024)

} 1 h 34 min

watch now
OncoViews on GI Cancers by Thibaud Kössler
Jun 19 2024
Gastrointestinal

GI Cancers (ASCO 2024)

} 1 h 31 min

watch now
OncoViews on Lung Cancer by Alfredo Addeo
Jun 12 2024
Lung Cancer

Lung Cancer (ASCO 2024)

} 1 h 32 min

watch now

Articles

Apostolos Sarivalasis
Apostolos Sarivalasis
Jan 22 2025
Women's Cancers
New Perspectives In The Early And Late Stages Of Cervical Cancer
FDA Approval
Intravenous Drip
Jan 20 2025
Women's Cancers
FDA Approves Dato-DXd for Advanced HR-Positive, HER2-Negative Breast Cancer
FDA Approval
Daughter holding mother's hand in hospital
Jan 17 2025
Gastrointestinal
FDA Approves Sotorasib & Panitumumab Combination for KRAS G12C-Mutated Metastatic Colorectal Cancer
PEAK Medicals
Jan 09 2025
Lung Cancer
Debate: Continuous Vs. Fixed-duration Immunotherapy
FDA Approval
Intravenous Drip
Dec 05 2024
Lung Cancer
FDA Approves New Therapies For NSCLC and SCLC
Jens Huober
Jens Huober
Nov 25 2024
Women's Cancers
Highlights from ESMO: Advancements in Early-Stage Triple-Negative Breast Cancer Treatments
Viktor Grünwald
Viktor Grünwald
Nov 18 2024
Urogenital
Breaking Down the Complexities of Non-Clear Cell RCC Entities
Swiss Approval
Blue Drug Capsules
Oct 11 2024
Lung Cancer
Swissmedic Approves Osimertinib for Locally Advanced EGFR-Positive NSCLC
FDA Approval
Drug capsules
Sep 30 2024
Lung Cancer, Women's Cancers
FDA Approvals Expand Treatment Options for Breast and Lung Cancers
PEAK Medicals
International Lung Cancer summit (ILCS)
Sep 20 2024
OncoNews
Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

MPN

Gabriela Baerlocher

Hirslanden Clinic Zurich, Switzerland

Sara Meyer

Inselspital, University Hospital Bern, Switzerland

AGENDA

Managing PV and MF: Integrating interferons, immunotherapies and new JAK2 inhibitors

Sara Meyer

Clinical significance of genomic testing in MPN: When to test what and what does it really mean?

TBD

Update on the management of CML: Navigating through the available and upcoming treatment options

Gabriela Baerlocher

2 CME Points by

SWISS SOCIETY OF HEMATOLOGY
(SGH • SSH)

Join our host, Sara Meyer, for an insightful roundtable on the latest progress in the treatment of myeloproliferative neoplasms (MPNs). This interdisciplinary roundtable gathers renowned experts to discuss groundbreaking findings, offering an in-depth exploration of new innovative therapeutic approaches for myelofibrosis, polycythaemia vera and chronic myeloid leukemia. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the treatment landscape of myeloproliferative neoplasms.

ADD THIS TO YOUR CALENDAR

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now